News
EW
86.96
+1.19%
1.02
Is a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?
NASDAQ · 1d ago
Weekly Report: what happened at EW last week (0415-0419)?
Weekly Report · 1d ago
What to Watch in the Week Ahead and on Monday, April 22
Tesla chief Elon Musk is expected to meet with India's Prime Minister Narendra Modi and announce plans to invest in and build a factory in the country. The week will see many major U.S companies release their financial report cards. Microsoft's revenue expected to have grown 15% as AI investments drive gains in the tech industry. A raft of economic data coming this week will be watched by the Federal Reserve policymakers.
Reuters · 4d ago
Will Acute Care Unit Aid Universal Health's (UHS) Q1 Earnings?
NASDAQ · 4d ago
Hologic (HOLX) Q2 Earnings Might Rise on GYN Surgical Growth
NASDAQ · 4d ago
Will Humana (HUM) Q1 Earnings Beat on CenterWell Strength?
NASDAQ · 4d ago
5 Large-Cap Medical Stocks to Buy Ahead of Q1 Earnings
NASDAQ · 4d ago
Will High Medical Care Ratios Hurt Molina's (MOH) Q1 Earnings?
NASDAQ · 4d ago
Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
NASDAQ · 5d ago
Press Release: Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024. The company plans to announce its operating results for the quarter ended March 31, 2024 after the market closes on Thursday. The conference call will be held at 5:00 p.m. ET that day.
Dow Jones · 5d ago
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
Edwards Lifesciences plans to announce its operating results for the quarter ended March 31, 2024 after the market closes on April 25, 2024. The company will host a conference call that day to discuss those results. The call will be available live and archived on the company's website.
Barchart · 5d ago
Is a Beat Likely for Edwards Lifesciences (EW) in Q1 Earnings?
NASDAQ · 6d ago
Hologic (HOLX) to Report Q2 Earnings: What's in the Cards?
NASDAQ · 6d ago
Truist Financial Reaffirms Their Buy Rating on Edwards Lifesciences (EW)
TipRanks · 6d ago
Is a Beat Likely for Intuitive Surgical (ISRG) in Q1 Earnings?
NASDAQ · 04/16 18:04
UnitedHealth Group (UNH) Tops on Q1 Earnings, Reaffirms EPS View
NASDAQ · 04/16 17:25
Align Technology (ALGN) to Post Q1 Earnings: What's in Store?
NASDAQ · 04/16 15:51
ITGR vs. EW: Which Stock Should Value Investors Buy Now?
NASDAQ · 04/16 15:40
What's in Store for Boston Scientific (BSX) in Q1 Earnings?
NASDAQ · 04/16 14:44
Zacks Industry Outlook Highlights Edwards Lifesciences, DexCom and STERIS
NASDAQ · 04/16 08:34
More
Webull provides a variety of real-time EW stock news. You can receive the latest news about Edwards Lifesciences Corp through multiple platforms. This information may help you make smarter investment decisions.
About EW
Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It also develops hemodynamic and noninvasive brain and tissue oxygenation monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra, and the Edwards SAPIEN 3 Ultra RESILIA systems, are catheter-based approaches for treating severe symptomatic aortic stenosis. It conducts operations worldwide and is managed in various geographical regions, including the United States, Europe, Japan, and Rest of World. It sells products that are used to treat advanced cardiovascular disease in all regions.